Novo Nordisk A/S ADR buy Rothschild & Co Redburn
Start price
16.09.25
/
50%
€48.55
Target price
16.09.26
-
Performance (%)
-16.17%
Price
17.12.25
€40.70
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -16.17%. This prediction currently runs until 16.09.26. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -3.095% | -3.095% |
| iShares Core DAX® | -1.212% | 1.925% |
| iShares Nasdaq 100 | -4.714% | -1.810% |
| iShares Nikkei 225® | -2.976% | -2.660% |
| iShares S&P 500 | -2.744% | -0.448% |
Comments by Rothschild___Co_Redb for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat